Close Menu

NEW YORK – NanoString Technologies said on Sunday that its preliminary revenues for the fourth quarter of 2019 grew to $36.6 million.

The figure would represent a 22 percent increase from the year-ago figure of $30.0 million and would beat the consensus Wall Street estimate of $34.0 million.

Product and service revenues are expected to be about $33.6 million, which would be a 42 percent increase from Q4 2018 and exceed the upper end of the firm's guidance range of $30 million to $32 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.